Sofia Gearty, fifth year student in the Tri-Institutional MD-PhD Program, has been awarded an F-30 Fellowship from the NIH's National Institute of Diabetes and Digestive Kidney Diseases for her project T cell Heterogeneity and Fate Diversification in Autoimmune Type I Diabetes.
Sofia is conducting research in the laboratory of Andrea Schietinger at the Sloan Kettering Institute at Memorial Sloan Kettering Cancer Center. Her work investigates how self-reactive CD8 T cells drive autoimmunity in a mouse model of type I diabetes, in particular how T cells with distinct fates mediate long-term autoimmune destruction of pancreatic beta cells. These studies will identify potential molecular targets for therapeutic interventions in type I diabetes and other T cell-mediated autoimmune diseases.
Sofia Gearty
Category:
- Awards